• About
• Links
• Contact
• Sitemap

Sitemap > Clinical Trials > Technology

• A Study of MabThera (Rituximab) Plus Standard Chemotherapy in Patients With Previously Untreated Mantle Cell Lymphoma.
• Bevacizumab and Abraxane as Second-Line Therapy in Triple Negative Metastatic Breast Cancer
• Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults
• PEPCAD III Substudy: Stem Cell Mobilization
• A Study of Bevacizumab in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
• Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
• Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children.
• Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above
• TYSABRI® Global Observational Program in Safety
• A Phase I/IIa Multicenter Dose-Escalation Study of Subcutaneous Intermittent Interleukin-7 CYT107 in Chronically HIV-Infected Patients With CD4 T-Lymphocyte Counts Between 101-400 Cells/mm(3) and Plasma HIV RNA Less Than 1000 Copies/ml After at Least 12 Months of HAART
• Bortezomib (Velcade) and Rituximab-HyperCVAD in Patients With Mantle Cell Lymphoma
• Open Label Extension of ISIS 301012 to Treat Familial Hypercholesterolemia
• A Phase II Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer
• M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma
• Cetuximab in Treating Patients At High Risk of Developing Stomach Cancer
• Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
• Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy
• Dendritic Cell Vaccine for High Risk Ovarian ca
• Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)
• A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients
• Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100
• Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer
• Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas in First Line of Treatment for the Metastatic Disease
• A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis
• Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma
• A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis
• Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)
• A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer
• Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer
• Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients
• Study of NGR-hTNF as Single Agent in Patients Affected by Metastatic Small Cell Lung Carcinoma
• A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma
• A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528
• A Study to Evaluate the Safety and Tolerability of Multiple IV Doses of an Antibody, in Patients With Systemic Lupus Erythematosus
• Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer
• Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
• Phase II Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL) of Total Lymphoid Irradiation (TLI) and Antithymocyte Globlulin (ATG) Followed by Matched Allogeneic Hematopoietic Transplantation as Consolidation to Autologous Hematopoietic Cell Transplantation (AHCT)
• Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin
• A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation
• Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in Healthy Females 10 - 25 Years of Age.
• A Study of Apomab in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer
• A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
• Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines
• Efficacy, Safety, Reactogenicity & Immunogenicity of the Human Rotavirus Vaccine (HRV) 444563 in Japanese Infants
• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
• Erythrocyte-Mediated Drug Delivery for the Prevention of Stent Restenosis
• A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) in Elderly Patients With Metastatic Colorectal Cancer.
• Gleevec & Docetaxel Study in Head and Neck Squamous Cell Cancer Patients
• A Phase II Study of EC17 (Folate-Hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma
• Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma
• A Study to Evaluate the Safety and Efficacy of Ocrelizumab in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis (FILM)
• A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Females Aged 15-25 Years.
• Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-Cyclophosphamide in Breast Cancer Patients
• Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults
• Rituximab and Prednisone as First-Line Therapy in Treating Patients With Low Levels of Platelets in the Blood
• A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma
• Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults
• A Study of the Safety and Effectiveness of CNTO 148 (Golimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (CR014179)
• A Study of the Safety and Effectiveness of CNTO 148 (Golimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (CR014188)
• Intermittent Chemotherapy With or Without GM-CSF for Metastatic HPRC
• Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids
• Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age
• Evaluation of Contrast-Enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases
• A Phase I Open-Label Study of the Safety and Immunogenicity of a Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for the Influenza Virus H5 Hemagglutinin Protein Administered Intradermally in Healthy Adults
• Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis
• A Study Evaluating the Efficacy and Safety of Sutent With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer
• Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children
• Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma
• Bevacizumab in Treating Patients With Primary Brain Tumor, Meningioma, or Head and Neck Cancer
• Bortezomib and Rituxan Study for Patients With Waldenstrom
• Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
• Combination Treatment of Relapsing-Remitting Multiple Sclerosis With Methylprednisolone and Interferon-Beta-1a
• Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC
• Phase II Trial of Cetuximab Alone and in Combination With Carboplatin in ER-Negative, PR-Negative, HER-2 Nonoverexpressing Metastatic Breast Cancers (LCCC 0403)
• Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta)
• Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults
• Immunogenicity and Safety of GSK Biologicals
• Phase 1, Open-Label, Dose Escalation Study of TRC093, in Patients With Locally Advanced or Metastatic Solid Tumors
• Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation
• Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy
• Interleukin 11, Thrombocytopenia, CML, Imatinib in CML Patients
• Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer
• Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas
• Ibritumomab Tiuxetan for Early Stage Indolent Lymphomas
• Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia
• Study of Nimotuzamab and Irintotecan in Metastatic Colorectal Cancer
• Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors
• SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome
• Campath in Chronic GVHD
• Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A
• Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer Breakthrough Pain
• DAHANCA 19: The Importance of the EGFr-Inhibitor Zalutumumab for the Outcome After Curative Radiotherapy for HNSCC
• Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus
• A Study of Apomab in Combination With Cetuximab and Irinotecan Chemotherapy in Patients With Previously Treated Metastatic Colorectal Cancer
• Rituximab in Progressive IgA Nephropathy
• Study Evaluating ACC-001 in Mild to Moderate Alzheimer
• Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
• Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
• Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
• A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18
• Six Months, Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation in Adolescents (>12 Years) and Adults With Moderate to Severe Persistent Allergic Asthma
• Study of Addition of Panitumumab to Chemoradiation Therapy in Subjects With Locally Advanced Head and Neck Cancer
• Evaluate Safety and Immunogenicity of a Pandemic Influenza Vaccine (GSK1119711A) in Children
• A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis.
• Study Evaluating Etanercept 25mg or 50mg Administered Subcutaneously to Healthy Chinese Male Subjects
• A Study of Re-Treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor
• Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan
• Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung
• Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma
• Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus
• A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to DMARD and/or Anti-TNF Therapy.
• TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)
• Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line Chemotherapy
• Study Using IMC-A12 With or Without Cetuximab in Patients With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFr Therapy
• Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)
• SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Bevacizumab, and Gemcitabine as First-Line Therapy in Treating Patients With Metastatic Breast Cancer
• A Study to Find Out How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
• Efficacy Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
• Rituximab and ABVD for Hodgkin
• Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis
• A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Agents.
• Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
• Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer
• Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis
• Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults.
• Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa Versus Individual Administration of Each Vaccine
• Safety and Efficacy Study of Plasmodium Falciparum LSA-3 Malaria Vaccine
• Aflibercept in Treating Patients With Myelodysplastic Syndromes
• Fludarabine, Cyclophosphamide, and Vaccine Therapy in Treating Patients With Metastatic Melanoma
• Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma
• Autologous Dendritic Cell Vaccine in HIV1 Infection
• Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab
• Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults
• Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients
• Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia
• A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory Asthma
• Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization
• APC8015F in Treating Patients With Progressive Metastatic Prostate Cancer
• Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus
• Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery
• A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis
• Panitumumab Plus Chemoradiotherapy and Induction Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck
• Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway Sensitivity
• Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
• Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
• Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania
• Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine
• Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer
• Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma
• Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer
• Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma
• Study Using IMC-1121B in Patients With Metastatic Renal Cell Carcinoma With Disease Progression on or Intolerance to Tyrosine Kinase Inhibitor Therapy
• Galiximab in Treating Patients With Relapsed or Refractory Hodgkin
• Safety, Immunogenicity and Preliminary Efficacy Study of Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine for Patients With Non-Small-Cell Lung Cancer (NSCLC) After Receiving Conventional First Line Chemotherapy
• Monoclonal Antibody Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
• A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer
• Natalizumab High Titer Immunogenicity and Safety
• A Study of Apomab in Combination With Rituximab in Patients With Non-Hodgkin
• Phase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast Cancer
• Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
• Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC
• A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma
• MK4721 in Patients With Advanced Hormone Refractory Prostate Cancer
• Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer
• A Phase I/IIa Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of an H5N1 Virus-Like Particle (VLP) Influenza Vaccine (Recombinant)
• Safety Study of ISIS 325568 in Healthy Volunteers
• Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment
• Vinflunine and Cetuximab as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
• A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-02)
• Study With IMC-A12 in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer
• Study of Safety and Effects of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma
• Broad Spectrum HPV (Human Papillomavirus) Vaccine (V505) in 16 to 26 Year Old Women
• A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01)
• First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu
• GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
• Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
• Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1)
• Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC
• Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma
• Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy
• Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer
• IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease
• An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety and Sustained Efficacy of Denosumab (AMG162) in the Treatment of Postmenopausal Osteoporosis
• A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma
• Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD
• Study of the Use of a Single Dose of Erythropoietin to Treat Acute Myocardial Ischemia
• Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
• Proleukin and Rapamune in Type 1 Diabetes
• Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients.
• Mono-Center, Double-Blind, Cross-Over Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles Versus Filtered Air on Airway Inflammation Induced by Segmental Allergen Challenge in Asthmatics
• A Study of Lintuzumab (SGN-33) in Combination With Low Dose Cytarabine in Patients 60+ Years With AML
• Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults.
• BEATRICE Study: A Study of Avastin (Bevacizumab)Adjuvant Therapy in Triple Negative Breast Cancer
• Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas
• A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Second-Line Treatment of Patients With DLBCL
• Evaluate Safety & Immunogenicity of GSK Bio CMV Vaccine in CMV-Seronegative Healthy Male Adult Subjects
• Eltrombopag to Initiate and Maintain Interferon Antiviral Treatment to Benefit Subjects With Hepatitis C Liver Disease
• A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled Trial Using CD133 Enriched Bone Marrow Cells Following Primary Angioplasty for Acute Myocardial Infarction
• A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies
• A Study of Tocilizumab in Combination With Methotrexate in Patients With Moderate to Severe Rheumatoid Arthritis
• A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer.
• Early Detection of Cardiotoxicity During Sunitinib or Sorafenib Chemotherapy Using Cardiac Biomarkers
• A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Chronic Lymphocytic Leukemia
• A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
• Non-Inferiority of Various GSK Bios Influenza Vaccine Presentations in Adults Aged 65 Years and Over.
• Phase II Safety and Efficacy Study of the Monoclonal Antibody CT-011 in Patients With Diffuse Large B-Cell Lymphoma Following Autologous Stem Cell Transplantation
• Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab
• Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer
• A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)
• Cell Therapy in Chronic Limb Ischemia
• Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Patients With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy
• Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Wks of Age
• Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults
• Effectiveness, Safety and Immunogenicity of GSK Biologicals HPV Vaccine GSK580299 Administered in Healthy Adolescents.
• Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™
• A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults
• Bevacizumab, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Previously Treated With Radiation Therapy and Temozolomide
• Tolerability of ALK Tree Tablet
• A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis
• PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (Study P05170)
• Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With CLL
• Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma
• Comparing Two Respiratory Drugs When Used In Combination And Separately From A Novel Inhaler Device In Healthy Subjects
• Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults
• Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment
• Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years
• Radioimmunotherapy in Prostate Cancer Using 177Lu-J591 Antibody
• A Study to Assess the Safety and Efficacy of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate
• Autologous Bone Marrow-Derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia
• Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
• SAR3419 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin
• Low Dose IL-2 for GVHD as GVHD Prophylaxis After Stem Cell Tranplantation
• A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN)
• Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma
• Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bios HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs
• Phase II Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases
• Study Comparing Cyclosporine With Infliximab in Steroid-Refractory Severe Attacks of Ulcerative Colitis
• Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer
• Rabbit Antithymoglobulin (rATG) in the Treatment of Patients With Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
• Study of NK012 in Patients With Refractory Solid Tumors
• Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL
• Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation
• Study Evaluating the Use of Etanercept in Patients With Ankylosing Spondylitis
• Revaccination With Influenza Vaccine GSK1247446A
• BEVACIZUMAB + LETROZOL vs LETROZOL as First Line Treatment in Postmenopausal Patients With Advanced or Metastatic Breast Cancer
• A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients
• A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
• A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma
• Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma
• ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
• A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.
• A Study of MabThera (Rituximab) in First Line Treatment of Chronic Lymphocytic Leukemia
• Bevacizumab Versus Ranibizumab for Diabetic Retinopathy
• Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers
• Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America
• Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma
• Preoperative Dose-Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer
• A Phase 1/2 Study of BMS-753493 in Subjects With Advanced Cancer
• Tolerability and Immunogenicity of RUTI Antituberculous Vaccine in Healthy Volunteers, Phase I Clinical Trial
• Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer
• Study Evaluating the Safety, Tolerability and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)
• Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults
• Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®
• Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
• ZOSTAVAX(TM) in Patients on Chronic/Maintenance Corticosteroids
• Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis, Study Two
• A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-Line Therapy in Patients With Advanced Gastric Cancer (AVAGAST)
• Multi-Dose-Escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-Cell Non Hodgkin
• Efficacy and Safety of Grass Sublingual Tablet in Children 5 to <18 Years of Age (Study P05239)
• Antibodies to Digoxin for Bipolar Disorder
• ZOSTAVAX(TM) Safety Study in Subjects 60 Years of Age or Older
• Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-Positive Breast Cancer (Study P05048)
• Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects
• A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL
• A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.
• Pertuzumab, Cetuximab, and Irinotecan in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
• Gemtuzumab and Combination Chemothearpy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
• Phase I Clinical and PK Study of CBP501 and Cisplatin Every 3 Weeks in Patients With Advanced Refractory Solid Tumors
• Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
• Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
• TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic
• Immunogenicity and Safety of GlaxoSmithKline Biologicals HPV Vaccine 580299 in Healthy Females 15 - 25 Years of Age
• A Prospective Open-Label Trial of Rituximab in Progressive Sarcoidosis
• Multi-Center, Open-Label Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohns Disease
• Phase II Study of Bevacizumab and Erlotinib
• Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-Cell Lymphoma With Neuromeningeal Invasion at Diagnosis
• Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM Vaccine
• G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer
• The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma
• CT-322 With or Without Irinotecan in Treating Patients With Recurrent Glioblastoma Multiforme
• Long-Term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis
• Efficacy and Safety From a Recombinant Folding Variant of Bet v 1
• Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
• A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy
• Phase IV Clinical Trial of an Influenza Split Vaccine Anflu
• XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma
• Alpha-Type-1 Dendritic Cell-Based Vaccines in Patients With Metastatic Colorectal Cancer
• High-Dose Methylprednisolone and Rituximab in High Risk B-CLL
• Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis
• A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer
• A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy
• CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
• A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
• A Phase I Study to Assess the Safety and Distribution of GT-111 in Patients With Advanced Metastatic Cancer
• A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer.
• Enzastaurin and Bevacizumab in Treating Patients With Recurrent Malignant Gliomas
• Phase II Study of the BiTE® MT103 in Patients With Minimal Residual Disease of B-Precursor Acute ALL
• Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone Vaccine
• Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC
• Immunogenicity and Safety of a 1-Dose Regimen of a Zoster Vaccine Versus Different 2-Dose Regimens in Subjects ≥ 70 Years
• Diffuse Large B Cell Lymphoma of the Adult: Randomisation Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab
• Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in theTreatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen
• Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma
• Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma
• Nimotuzumab in Adults With Pancreatic Cancer
• Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma
• Efficacy and Safety of Grass Sublingual Tablet in Adults (Study P05238)
• Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia
• AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma
• CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
• Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 Years
• Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia
• Combination of GTI 2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)
• Rituximab for Prevention of Rejection After Renal Transplantation
• Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
• Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection
• A Phase II Trial of Bevacizumab in Myelodysplastic Syndromes (Int-1, Int-2 and High Risk According to IPSS) With Excess of Marrow Blasts
• Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
• A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of Response
• Activated White Blood Cells in Treating Patients Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Stage II or Stage III Multiple Myeloma
• Phase IB, Multicenter, Randomized, Double-Blind Placebo-Controlled, Dose-Escalation Study w/Open-Label Extension to Evaluate Safety and Tolerability of Multiple IV Doses of MEDI-545; A Fully Human Anti-IFN-Alpha Monoclonal Antibody in Patients w/SLE
• Biomarkers in the Diagnosis and Assessment of PAH
• Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions
• Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma
• A Phase III Trials Program Exploring the Integration of Bevacizumab, Everolimus (RAD001), and Lapatinib Into Current Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer (GeparQuinto)
• A Trial of LBH589 and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer Whose Disease Has Progressed on or After Trastuzumab
• Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
• Study of Two Formulations of GSK Biologicals' Varicella Vaccine
• Rituximab Combined With ESHAP in Patients With Relapse or Refractory DLBCL
• Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
• Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer
• Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Patients With Advanced or Metastatic Solid Tumors
• Molecular Analysis of Breast Cancer
• A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration
• Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
• Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors (-)
• Vaccine Therapy in Treating Patients Who Have Undergone Autologous Stem Cell Transplant for High-Risk Lymphoma or Multiple Myeloma
• Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer
• Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
• Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)
• Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer
• A Post Marking Study to Evaluate the Safety of FluMist in Children
• Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma
• The Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Major Depressive Disorder
• Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
• VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin
• Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer
• Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Healthy Vietnamese Women According to a 0, 1, 6 Month Schedule
• Clofarabine, Melphalan, and Alemtuzumab Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Diseases
• A Study to Evaluate the Safety and Immunogenicity of V710 in Adults With Kidney Disease on Hemodialysis
• Multipeptide Vaccine for Advanced Breast Cancer
• Treatment of Localized Prostate Cancer With High Intensity Focused Ultrasound Using the Sonablate® 500 System in Canada
• Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis (CHASE)
• ABI-009 (Nab-Rapamycin) in Patients With Advanced Non-Hematologic Malignancies
• Long-Term Open-Label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
• Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment (BELIEVE)
• HuMax-CD38 Safety Study in Multiple Myeloma
• Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer
• Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD
• Study Evaluating the Safety, Tolerability and Immunogenicity of 13vPnC as a 2-Dose Regimen or With 23vPS
• Trial for Locally Advanced Her2 Positive Breast Cancer Using Paclitaxel, Trastuzumab, Doxorubicin and Cyclophasmide on a Weekly Basis
• A Study to Test the Safety & Effectiveness of Docetaxel With RAD001 & Bevacizumab in Men With Advanced Prostate Cancer
• Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants
• Obatoclax Mesylate, Fludarabine and Rituximab in Previously Treated Patients With B-CLL
• Safety Study of Vaccinia Virus to Treat Superficial Injectable Tumors
• A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.
• Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
• Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
• OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.
• Yttrium Y 90 Ibritumomab Tiuxetan, Rituximab, Fludarabine, Melphalan, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin Lymphoma
• Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer
• A Phase II Pilot Study of the Combination of (MEL-VTD)
• Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
• Evaluation of Safety and Immunogenicity of co-Administering HPV Vaccine With Another Vaccine in Healthy Female Subjects.
• Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age
• SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
• Belatacept Pharmacokinetic Trial in Renal Transplantation
• Rituximab in Rheumatoid Arthritis Lung Disease
• T-Reg Cell Kinetics for Pts Receiving Alemtuzumab and Undergoing SCT From HLA Mismatched-Related or HLA Matched or Mismatched Unrelated Donors (REGALE)
• A Phase I, Randomized, Double-Blind, Single-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-557
• Preoperative Cisplatin and Bevacizumab in ER-, PR-, Her-2 Negative Breast Cancer
• Peanut Sublingual Immunotherapy
• Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell Lymphoma
• Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83 (VEE C-84)
• Ibritumomab Tiuxetan + Rituximab Maintenance
• Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer
• Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Solid Cancer
• Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer (APP22)
• Phase I & II Trial of Intravesicular Abraxane for Treatment-Refractory Bladder Cancer (Abraxane)
• A Randomized, Controlled Trial of Replication-Competent Adenovirus-Mediated Suicide Gene Therapy in Combination With IMRT Versus IMRT Alone for the Treatment of Newly-Diagnosed Intermediate-Risk Prostate Cancer
• Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients
• A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer (NSCLC)
• Safety and Immunogenicity Study of Rift Valley Fever Vaccine (RVF)
• An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated Hayfever
• Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn
• Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer
• Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment
• Safety and Immunogenicity of GlaxoSmithKline Biologicals HPV Vaccine 580299 in HIV Infected Females
• Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants
• A Blinded, Randomized, Phase I Study of Brivanib Alaninate vs Placebo in Combination With Erbitux (Cetuximab) and Irinotecan in Subjects With Metastatic Colorectal Cancer (MCRC)
• Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer
• Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma
• Study of Atacicept in Anti-TNFα-naïve Patients With Moderate to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate
• Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Newly-Diagnosed Primary CNS Lymphoma (PCNSL)
• Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic Asthma
• Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma
• Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease
• Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis C (PLUS)
• Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
• Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- Tarceva. (ACT)
• Cyclophosphamide, Alemtuzumab, Total-Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Severe Aplastic Anemia
• A Phase 2a/2b Multicenter, Open-Label Study to Evaluate NKTR 102 (PEG-Irinotecan) in Combination With Cetuximab Versus Irinotecan in Combination With Cetuximab in Second Line Colorectal Cancer Patients
• Safety, Pharmacokinetics, and Pharmacodynamics of SD-101 in Healthy Normal Males
• Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic Adenocarcinoma
• Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer
• 2-Arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab
• Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-Endemic Region
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
• A Study of an Antibiotic Implant in General Surgical Subjects at Higher Risk for Surgical Wound Infection
• Efficacy Study of an Anti-TNF Alpha Agent in Patients With Hand Osteoarthritis (DORA)
• T Lymphocytes and Anti-CD45 Monoclonal Antibody in Treating Patients With Advanced Neuroblastoma
• A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With T-Cell Diseases
• Cyclophosphamide and Fludarabine Followed By Autologous Gene-Modified Lymphocytes, Vaccine Therapy, and High-Dose Aldesleukin in Treating Patients With Metastatic Melanoma
• A Phase I Study to Evaluate the Safety and Immunogenicity of an Ebola DNA Plasmid Vaccine, VRC-EBODNA023-00-VP, and a Marburg DNA Plasmid Vaccine, VRC-MARDNA025-00-VP, in Healthy Adults
• Pharmacokinetics Study of Liposomal Paclitaxel in Humans (LPS-PK-H)
• Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Primary Refractory Lymphoma
• Safety and Efficacy Study of GCS-100 in the Treatment of Multiple Myeloma
• Naproxen in Preventing Bone Pain Caused by Pegfilgrastim in Patients With Non-Hematologic Cancer Undergoing Chemotherapy
• Gene-Modified Tumor Cells in Treating Patients With B-Cell Chronic Lymphocytic Leukemia
• Lapatinib and/or Trastuzumab With or Without Paclitaxel in Treating Patients With HER2-Positive Breast Cancer Who Have Undergone Surgery
• Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
• Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
• Pre-Surgical Detection of Clear Cell Renal Cell Carcinoma Using Radiolabeled G250-Antibody
• CerviPrep™ for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial Cancer, Cervical Cancer, or Ovarian Epithelial Cancer
• Safety and Efficacy of CJ-50300 in Healthy Volunteers
• Study Registry to Evaluate the Long-Term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease.
• Safety Study of XmAb™2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma
• Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors
• Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Solid Tumors That Did Not Respond to Treatment
• Safety of Ibritumomab Tiuxetan (Zevalin®) in Combination With a Fudarabine-Based Reduced Intensity Conditioning (RIC) Regimen (ZEVALLO 2007)
• T Lymphocytes and Anti-CD45 Monoclonal Antibody in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer
• Safety and Efficacy of Combination HDI and Anti-CTLA4 for Recurrent Inoperable Stage III or Stage IV Melanoma
• Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
• Anti-CD45 Monoclonal Antibody, Alemtuzumab, and Fludarabine Followed By Donor Stem Cell Transplant in Treating Children With Severe Combined Immunodeficiency Disease or Other Primary Immunodeficiency Disorder
• A Phase I/IIa Study of the Safety, Immunogenicity and Parasite Growth Inhibitory Activity of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria
• Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059 AM2)
• Study to Assess the Safety and Efficacy of ISIS 301012 in Homozygous Familial Hypercholesterolemia (RADICHOL1)
• Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
• Effect of Topical Calcipotriene/Betamethasone (Taclonex)in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva)
• Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer
• Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens
• Vaccine Therapy in Treating Patients With Malignant Glioma
• Genomics of Chronic Renal Allograft Rejection (The GoCAR Study)
• Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
• Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
• A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients
• Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults
• Gemcitabine and Erlotinib With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
• Sulforaphane as an Antagonist to Human PXR-Mediated Drug-Drug Interactions
• PR-104 and G-CSF in Treating Patients With Solid Tumors
• Aflibercept in Treating Young Patients With Relapsed or Refractory Solid Tumors
• Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above
• Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy Adults
• Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer
• A Ph III, Multicenter Placebo-Controlled, Randomized, Double-Blind Study to Evaluate Safety/Efficacy of PROCHYMALTM IV Infusion for Induction of Remission in Subjects Experiencing Treatment of Refractory Moderate to Severe Crohn
• Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer
• A Phase 2 Study of AVONEX in Ulcerative Colitis
• Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
• Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients
• Phase II Breast Cancer Treatment Using Weekly Carboplatin+Nab-Paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-)
• Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Patients (DIA-AID)
• Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children
• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Vorinostat in Treating Women With Breast Cancer That Can Be Removed by Surgery
• Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
• Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
• Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
• Long Term Safety of MLN0002 in Patients With Ulcerative Colitis and Crohn
• Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer
• Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed MM
• Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia or Other Hematologic Disorder
• Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies
• Efficacy and Safety From a High-Dosed Sublingual Grass Pollen Preparation (ALLEGRA6)
• High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Germ Cell Tumors
• A Phase 3 Trial of the Effect of Motavizumab Prophylaxis on Reduction of Serious Early Childhood Wheezing in Infants
• A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer.
• Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery
• Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
• Study to Assess the Efficacy and Safety of Transplanting Autologous Skeletal Myoblasts, Into Infarcted Heart, Using an Catheter Delivery System (CAuSMIc II)
• Chemotherapy, Radiation Therapy, and Vaccine Therapy With or Without Daclizumab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery
• Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy
• Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Recovering From Lymphopenia Caused by Temozolomide
• Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Toddlers
• Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation
• Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
• A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer (FP253-GDEPT)
• A Study of Efficacy of New Doses of Xolair to Protect From Allergen Challenge in Groups of Asthma Patients Defined by IgE Levels
• Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma
• Multi-Center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
• Alemtuzumab, Fludarabine, Melphalan, and a Donor Stem Cell Transplant in Treating Young Patients With Resistant Langerhans Cell Histiocytosis
• Study of IMC-1121B in Patients With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy
• Fludarabine, Busulfan, and Alemtuzumab Followed By Donor Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disease
• Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers
• Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function
• A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer (BNIT-PR-001)
• Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-Infected Subjects
• Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix
• Study of Ipilimumab to Treat Melanoma in Patients With Brain Metastases
• Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer
• Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma
• Study Comparing Bevacizumab + Temsirolimus Vs Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
• Phase 1 Clinical Trial in Patients With Advanced Malignancies
• Safety and Efficacy of Infliximab in Palmoplantar Psoriasis
• A Phase IV, Randomised Study to Evaluate the Immune Response of UK Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life (Sched2)
• Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer
• Lenalidomide in Treating Patients With Progressive or Recurrent Multiple Myeloma After a Donor Stem Cell Transplant
• Daclizumab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia
• Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
• Efficacy, Safety and Pharmacokinetic Profile of a Collagen Bupivacaine Implant in Men After Open Mesh Herniorrhaphy
• AMG 655/Panitumumab Combination mCRC Study
• Vaccine Therapy and Chemotherapy With or Without Tretinoin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
• Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study)
• Rituximab in Treating Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant
• A Study to Evaluate Oreclizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)
• Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab (BETH)
• Cell Transfer Study for Potential Cell-Based Therapies to Treat Human Disease and Disability
• Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer (With Trastuzumab in HER2 Positive Patients)
• Long-Term Treatment Effect of DiaPep277 in Type 1 Diabetes
• Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer (CDX1307-02)
• A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer.
• Safety and Immunogenicity of a Melan-A VLP Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients
• FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer (TOSCA)
• IMC-A12 in Treating Patients With Advanced Liver Cancer
• Radiolabeled Monoclonal Antibody, Gemcitabine, and Hepatic Arterial Infusion of Floxuridine in Treating Patients With Metastatic Colorectal Cancer and Liver Metastases
• Open-Label, Randomized Trial to Evaluate Safety of Technosphere Insulin (T/I) in Type 1&2 Diabetics With Mild COPD
• T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
• Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma
• A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer
• Study Evaluating Single Doses of SBI-087 in Subjects With Rheumatoid Arthritis
• The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis (BSX-003)
• Ofatumumab Dose-Finding in RRMS Patients
• Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes
• Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery
• UMCC 2006.119 Phase I/II Trial of MK-0752 Followed by Docetaxel in Locally Advanced or Metastatic Breast Cancer: A Study by the Stem Cell Clinical Consortium
• Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine co-Administered With Another Vaccine in Healthy Female Subjects
• Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Lymphocytic Leukemia
• Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus (SCT)
• Sitagliptin Plus Granulocyte-Colony Stimulating Factor in Acute Myocardial Infarction (SITAGRAMI)
• Immunogenicity of GSK Biologicals Pandemic Influenza Vaccine (GSK1562902A) at Different Vaccination Schedules
• Mechanism of Action of Galiximab in Subjects With Previously Untreated Follicular Non-Hodgkins lymphoma
• A Phase I, Randomized, Single-Blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18- 40 Years of Age
• Transplantation With Ybritumomab Tiuxetan (Zevalin) Plus BEAM Regimen in Patients With Refractory Large B-Cell Difusse Lymphom (Z-BEAM LDGGB)
• Aprepitants Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients
• Viral Therapy in Treating Patients With Metastatic Melanoma
• Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer
• Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer
• A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis
• Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A in Treating Patients With Advanced Solid Tumors
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
• A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
• Cetuximab With or Without Brivanib in Treating Patients With Metastatic Colorectal Cancer
• Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine
• Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer
• Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RADOO1
• A Phase I Dose Escalation Study of Weekly SGN-35 Alone and in Combination With Gemcitabine in HL
• Randomized Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
• Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
• Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama
• Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer
• Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
• Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-Infected Men
• Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
• Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors
• Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM), Who Have Failed Previous Mobilization
• REGENESIS: A Phase II Prospective, Randomized, Double-Blind, Placebo Controlled Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients
• Anti-CD25 Immunotoxin IMTOX25 in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma
• A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
• Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III)
• Vaccine Therapy and Cyclophosphamide in Treating Patients Who Has Undergone Surgery for Liver Metastases Due to Colorectal Cancer
• A Phase 1, Single Center, Dose Escalation Study of CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
• Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
• CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy
• Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia
• Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib
• ZAR2007: R-CHOP in Folicular Lymphoma Patients no Treated Previously. Consolidation With 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®)
• Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals HBV Vaccine
• Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-Vaccinated Subjects
• A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma